
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration is advising that all HIVers be given a genetic test before taking the anti-HIV drugs Ziagen, Trizivir, and Epzicom to determine if they carry a gene making them prone to allergic reactions to the abacavir in the treatments. Genetic screening could reduce the incidence of severe allergic reactions from 7.8% to 3.4%, says drugmaker GlaxoSmithKline.
From our Sponsors
Most Popular
Plus: Featured Video